Storia in 2 fonti

Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr

Alembic Pharma reports a 12.1% increase in Q1 net profit to ₹173.07 crore, driven by strong business growth.

Raccontata da

thehindubusinessline.com

thehindu.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo3 g fa

Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr

Alembic Pharma reports a 12.1% increase in Q1 net profit to ₹173.07 crore, driven by strong business growth.

originale

thehindu.com2 g fa

Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms

Aurobindo Pharma riporta net profit +25.2% YoY (₹1,032 cr) e revenue +16.3% (₹9,150 cr) nel Q1 FY27, trainato da formulations U.S. +8.1% ed Europa +25.6%. Merger di tre subsidiary riduce overhead; trend di razionalizzazione rilevante per decisioni M&A e organizational efficiency.

Leggi questa versione →

Timeline cronologica

martedì 4 agosto 2026·thehindubusinessline.com
Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr
Alembic Pharma reports a 12.1% increase in Q1 net profit to ₹173.07 crore, driven by strong business growth.
mercoledì 5 agosto 2026·thehindu.com
Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms
Aurobindo Pharma's Q1 net profit rises 25% to ₹1,032 crore, driven by strong revenue growth across its businesses.

Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr

Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms

Timeline cronologica

Alembic Pharma Q1 net profit up 12.1% at ₹173.07 cr

Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms

Aurobindo Pharma Q1 profit rises 25% as revenue hits record ₹9,150 crore